Clinical Trial NCT06238544

Trial

Chengdu Suncadia Medicine – HRS-5965-203 (NCT06238544)

Clinical trial ID

NCT06238544

Drug name

HRS-5965

Company:

Chengdu Suncadia Medicine Co., Ltd

Drug trade name

Clinicaltrials.gov

Learn more

Phase of study

2

Current status

Recruiting

Start

02/2024

Substance

HRS‑5965 (oral tablets)

Research question

Long‑term safety and tolerability of HRS‑5965 tablets in patients with PNH who previously completed initial HRS‑5965 studies and who may continue benefiting from treatment

Delivery method of drug

Frequency

Clinical trial locations

China